A detailed history of Toth Financial Advisory Corp transactions in Repligen Corp stock. As of the latest transaction made, Toth Financial Advisory Corp holds 120 shares of RGEN stock, worth $19,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 120 -0.0%
Holding current value
$19,078
Previous $17,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 25, 2021

BUY
$148.08 - $206.57 $4,146 - $5,783
28 Added 30.43%
120 $23,000
Q2 2020

Jul 14, 2020

BUY
$94.33 - $140.48 $8,678 - $12,924
92 New
92 $11,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.82B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.